Page last updated: 2024-12-06

n,n'-dibutylurea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

n,n'-dibutylurea is a synthetic compound that can be prepared through the reaction of dibutylamine with urea. It has been studied for its potential applications in various fields, including agriculture, pharmaceuticals, and materials science. n,n'-dibutylurea is known to exhibit herbicidal activity, inhibiting the growth of certain weeds and crops. It is also used as a plasticizer in polymers, enhancing their flexibility and durability. The compound's importance stems from its versatility and potential to contribute to advancements in these diverse areas. Researchers are investigating n,n'-dibutylurea's properties to optimize its use and explore its potential in developing novel products and solutions.'

N,N'-dibutylurea: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID74523
CHEMBL ID3186549
SCHEMBL ID320112
MeSH IDM0463626

Synonyms (37)

Synonym
1792-17-2
nsc-131939
urea,n'-dibutyl-
nsc131939
n,n'-di-n-butylurea
1,3-dibutylurea
1,3-dibutyl-urea
dibutylurea
dtxcid1022188
cas-1792-17-2
NCGC00255913-01
tox21_301353
dtxsid3042188 ,
AKOS006230359
ai3-14904
j2hug1i10w ,
unii-j2hug1i10w
nsc 131939
einecs 217-258-7
1,3-dibutyl urea
urea, n,n'-dibutyl-
n,n'-dibutylurea
FT-0606633
dibutylurea, n,n'-
BP-30059
SCHEMBL320112
1,3-di(n-butyl)urea
CHEMBL3186549
mfcd00015229
nn'-dibutylurea
n,n inverted exclamation mark -dibutylurea
SY037877
F20434
Q27281062
A881269
AS-57154
PD065618
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency68.58960.001022.650876.6163AID1224838
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency76.95880.003041.611522,387.1992AID1159552
Caspase-7Cricetulus griseus (Chinese hamster)Potency68.58960.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency68.58960.006723.496068.5896AID1346980
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (46.67)29.6817
2010's7 (46.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.64 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]